Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate)-Reference-Cited by-同舟云学术

Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate)

Published:2019-02-01 Issue:2 Volume:42 Page:164-172
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Suzuki Hikari¹,Bando Kanan²,Tada Hiroyuki³,Kiyama Tomomi⁴,Oizumi Takefumi¹,Funayama Hiromi⁵,Sugawara Shunji³,Takahashi Tetsu¹,Endo Yasuo¹

Affiliation:

1. Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University

2. Division of Orthodontics and Dentofacial Orthopedics, Graduate School of Dentistry, Tohoku University

3. Division of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku University

4. Division of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku University

5. Department of Pediatric Dentistry, Tsurumi University School of Dental Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/2/42_b18-00408/_pdf

Reference44 articles.

1. 1) Fleisch H. Diphosphonates: history and mechanisms of actions. Metab. Bone Dis. Relat. Res., 3, 279–287 (1981).

2. 2) Rogers MJ, Crockett JC, Coxon FP, Mönkkönen J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone, 49, 34–41 (2011).

3. 3) Endo Y, Kumamoto H, Nakamura M, Sugawara S, Takano-Yamamoto T, Sasaki K, Takahashi T. Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biol. Pharm. Bull., 40, 739–750 (2017).

4. 4) Geddes AD, D’Souza SM, Ebetino FH, Kenneth JI. Bisphosphonates: structure–activity relationships and therapeutic implications. Bone and Mineral Research. (Heershe NM, Kanis JK ed). Vol. 8, Elsevier Science BV, Amsterdam, Holland, pp. 265–306 (1994).

5. 5) Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V. The acute phase response after bisphosphonate administration. Calcif. Tissue Int., 41, 326–331 (1987).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteonecrosis of the jaw in a patient treated with alendronate and then denosumab: A case of dramatic amelioration by minocycline and then etidronate;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-08

2. Effect of local administration of bisphosphonate on orthodontic anchorage – A systematic review of animal studies;journal of orthodontic science;2022

3. In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response;Scientific Reports;2021-07-20

4. Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates;YAKUGAKU ZASSHI;2020-01-01